Early onset deficits on the delayed alternation task in the Hdh Q92 knock-in mouse model of Huntington's disease

Brain Research Bulletin

Volumn 88, Issue 2-3, 2012, Pages 156-162

  Trueman, R C ^a   Jones, L ^b   Dunnett, S B ^a   Brooks, S P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

9 Hole box; Cognitive impairment; Delayed alternation; HdhQ92 mice; Huntington's disease; Knock in mice; Operant tests

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DELAYED ALTERNATION TASK; FEMALE; HUNTINGTON CHOREA; LEARNING; MALE; MENTAL TASK; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TASK PERFORMANCE;

AGE OF ONSET; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; HUNTINGTON DISEASE; LEARNING DISORDERS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REACTION TIME; ROTAROD PERFORMANCE TEST;

EID: 84860828469     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.03.012     Document Type: Article

References (44)

1. Aron A.R., Watkins L., Sahakian B.J., Monsell S., Barker R.A., Robbins T.W. Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function. J. Cogn. Neurosci. 2003, 15:629-642.
2. Bates G., Harper P.S., Jones L. Huntington's Disease 2002, Oxford University Press, Oxford.
3. Q92/Q92 mouse line. Brain Res. Bull. 2011.
4. Bode F.J., Stephan M., Suhling H., Pabst R., Straub R.H., Raber K.A., Bonin M., Nguyen H.P., Riess O., Bauer A., Sjoberg C., Petersen A., von Horsten S. Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum. Mol. Genet. 2008, 17:2595-2609.
5. Brooks S., Higgs G., Jones L., Dunnett S.B. Longitudinal analysis of the behavioural phenotype in Hdh(Q92) Huntington's disease knock-in mice. Brain Res. Bull. 2010, 10.1016/j.brainresbull.2010.05.003.
6. Craufurd D., Snowden J. Neuropsychological and Neuropsychiatric Aspects of Huntington's Disease 2002, 62-94. Huntington's Disease Oxford University Press, Oxford. G. Bates, P. Harper, L. Jones (Eds.).
7. Divac I., Markowitsch H.J., Pritzel M. Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Res. 1978, 151:523-532.
8. Dunnett S.B., Iversen S.D. Neurotoxic lesions of ventrolateral but not anteromedial neostriatum in rats impair differential reinforcement of low rates (DRL) performance. Behav. Brain Res. 1982, 6:213-226.
9. Dunnett S.B., Nathwani F., Brasted P.J. Medial prefrontal and neostriatal lesions disrupt performance in an operant delayed alternation task in rats. Behav. Brain Res. 1999, 106:13-28.
10. Gray M., Shirasaki D.I., Cepeda C., Andre V.M., Wilburn B., Lu X.H., Tao J., Yamazaki I., Li S.H., Sun Y.E., Li X.J., Levine M.S., Yang X.W. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 2008, 28:6182-6195.
11. Hanes K.R., Andrewes D.G., Pantelis C. Cognitive flexibility and complex integration in Parkinson's disease, Huntington's disease, and schizophrenia. J. Int. Neuropsychol. Soc. 1995, 1:545-553.
12. Ho A.K., Sahakian B.J., Brown R.G., Barker R.A., Hodges J.R., Ane M.N., Snowden J., Thompson J., Esmonde T., Gentry R., Moore J.W., Bodner T. Profile of cognitive progression in early Huntington's disease. Neurology 2003, 61:1702-1706.
13. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 1999, 23:181-192.
14. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
15. Jacobsen C.F Studies of cerebral function in primates. I. The functions of the frontal association areas in monkeys. Comp. Psychol. Monogr. 1936, 13:3.
16. Jacobsen C.F. Studies of cerebral function in primates. IV. The effect of frontal lobe lesions on the delayed alternation habit in monkeys. J. Comp. Psychol. 1937, 23:101.
17. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., Cepeda C., Calvert C.R., Jokel E.S., Klapstein G.J., Ariano M.A., Levine M.S., DiFiglia M., Aronin N. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 2001, 21:9112-9123.
18. Lange K.W., Sahakian B.J., Quinn N.P., Marsden C.D., Robbins T.W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J. Neurol. Neurosurg. Psychiatry 1995, 58:598-606.
19. Larsen J.K., Divac I. Selective ablations within the prefrontal cortex of the rat and performance of delayed alternation. Physiol. Psychol. 1978, 6:15-17.
20. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119(Pt 5):1633-1645.
21. Levine M.S., Klapstein G.J., Koppel A., Gruen E., Cepeda C., Vargas M.E., Jokel E.S., Carpenter E.M., Zanjani H., Hurst R.S., Efstratiadis A., Zeitlin S., Chesselet M.F. Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res. 1999, 58:515-532.
22. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., Ren S., Li X.J., Albin R.L., Detloff P.J. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 2001, 10:137-144.
23. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
24. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., Chesselet M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 2003, 465:11-26.
25. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., Cummings J.L. Neuropsychiatric aspects of Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2001, 71:310-314.
26. Reddy P.H., Williams M., Charles V., Garrett L., Pike-Buchanan L., Whetsell W.O., Miller G., Tagle D.A. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 1998, 20:198-202.
27. Sathasivam K., Woodman B., Mahal A., Bertaux F., Wanker E.E., Shima D.T., Bates G.P. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients. Hum. Mol. Genet. 2001, 10:2425-2435.
28. Schilling G., Becher M.W., Sharp A.H., Jinnah H.A., Duan K., Kotzuk J.A., Slunt H.H., Ratovitski T., Cooper J.K., Jenkins N.A., Copeland N.G., Price D.L., Ross C.A., Borchelt D.R. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 1999, 8:397-407.
29. Shelbourne P.F., Killeen N., Hevner R.F., Johnston H.M., Tecott L., Lewandoski M., Ennis M., Ramirez L., Li Z., Iannicola C., Littman D.R., Myers R.M. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet. 1999, 8:763-774.
30. Slow E.J., Graham R.K., Osmand A.P., Devon R.S., Lu G., Deng Y., Pearson J., Vaid K., Bissada N., Wetzel R., Leavitt B.R., Hayden M.R. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11402-11407.
31. Slow E.J., van Raamsdonk J., Rogers D., Coleman S.H., Graham R.K., Deng Y., Oh R., Bissada N., Hossain S.M., Yang Y.Z., Li X.J., Simpson E.M., Gutekunst C.A., Leavitt B.R., Hayden M.R. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 2003, 12:1555-1567.
32. Sokolowski J.D., Salamone J.D. Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res. 1994, 642:20-28.
33. Teichmann M., Dupoux E., Kouider S., Bachoud-Levi A.C. The role of the striatum in processing language rules: evidence from word perception in Huntington's disease. J. Cogn. Neurosci. 2006, 18:1555-1569.
34. Teichmann M., Dupoux E., Kouider S., Brugieres P., Boisse M.F., Baudic S., Cesaro P., Peschanski M., Bachoud-Levi A.C. The role of the striatum in rule application: the model of Huntington's disease at early stage. Brain 2005, 128:1155-1167.
35. Thompson J.C., Snowden J.S., Craufurd D., Neary D. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. J. Neuropsychiatry Clin. Neurosci. 2002, 14:37-43.
36. Trueman R.C., Brooks S.P., Dunnett S.B. Implicit learning in a serial choice visual discrimination task in the operant 9-hole box by intact and striatal lesioned mice. Behav. Brain Res. 2005, 159:313-322.
37. Trueman R.C., Brooks S.P., Jones L., Dunnett S.B. The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease. Eur. J. Neurosci. 2007, 25:551-558.
38. Trueman R.C., Brooks S.P., Jones L., Dunnett S.B. Time course of choice reaction time deficits in the Hdh(Q92) knock-in mouse model of Huntington's disease in the operant serial implicit learning task (SILT). Behav. Brain Res. 2008, 189:317-324.
39. Trueman R.C., Brooks S.P., Jones L., Dunnett S.B. Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington's disease. Behav. Brain Res. 2009, 203:215-222.
40. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarmann A., Rathke-Hartlieb S., Schulz J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer B., Bauer A., Li X.J., Riess O. Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 2003, 12:617-624.
41. Wheeler V.C., Auerbach W., White J.K., Srinidhi J., Auerbach A., Ryan A., Duyao M.P., Vrbanac V., Weaver M., Joyner A.L., MacDonald M.E. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum. Mol. Genet. 1999, 8:115-122.
42. Wheeler V.C., White J.K., Gutekunst C.A., Vrbanac V., Weaver M., Li X.J., Li S.H., Yi H., Vonsattel J.P., Gusella J.F., Hersch S., Auerbach W., Joyner A.L., MacDonald M.E. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet. 2000, 9:503-513.
43. White J.K., Auerbach W., Duyao M.P., Vonsattel J.P., Gusella J.F., Joyner A.L., MacDonald M.E. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 1997, 17:404-410.
44. Yamamoto A., Lucas J.J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000, 101:57-66.